News
A retrospective chart review was conducted to identify all patients who indicated fibromyalgia as a primary reason for seeking medical cannabis and completed at least 1 follow-up visit at Harvest ...
Raphael Mechoulam, PhD, speaks during the Marijuna Conference at the Barbizon Plaza Hotel in New York, on May 20, 1971. Known as the ‘father of cannabis research,’ Dr. Mechoulam died on March 9, 2023, ...
Every year, an estimated 700,000 to 1.27 million individuals die of infection with microorganisms that have acquired resistance to antimicrobial therapy, such as methicillin-resistant Staphylococcus ...
The interaction between the endocannabinoid and immune system is intricate, and it appears to modulate both innate and adaptive immune responses.
Credit: Getty Images. A medical school professor investigates why the endocannabinoid system isn't taught in American medical schools. The ECS is often described as only being in the nervous and ...
David Meiri, PhD, was a keynote speaker at CannMed ’23 in Marco Island FL. Credit: Larry Luxner AJEM interviews Israeli cannabis researcher David Meiri, PhD, after his keynote address at CannMed '23 ...
Professor Yossi Tam, DMD, PhD, MSc, BMedSc, Director of Israel’s Multidisciplinary Center for Cannabinoid Research, has devoted his career to cannabis research. Credit: Larry Luxner. The ...
The objective of this study was to examine levels of anxiety, and depression as a comorbidity, among patients who received an authorized medical cannabis prescription from a Canadian multidisciplinary ...
Pain scale. Credit: Getty Images. New preclinical research in Neuron suggests the utility of a cholinergic circuit to relieve pain despite opioid tolerance. Researchers from the University of Chicago ...
Glioblastoma multiforme (GBM), also called grade IV astrocytoma, is an aggressive, malignant brain tumor with a low treatment success rate, particularly in patients with immune checkpoint-active ...
Credit: Getty Images. When it comes to treating chronic illness, the healthcare industry as a whole is in the process of a paradigm shift away from single molecule therapies and toward combination ...
In this episode, we talk with Yale-trained psychiatrist Jordan Sloshower, MD, MSc, about how psychedelic-assisted therapies can promote psychological flexibility, findings from his recent study on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results